| Product |
CAS |
Molecular formula |
More |
| Bucindolol |
70369-47-0 |
C22H26ClN3O2 |
More |
| Norverapamil |
67018-85-3 |
C26H37ClN2O4 |
More |
| (9Beta,11beta,16beta)-17,21-dihydroxy-16-methyl-9,11-epoxypregna-1,4-d |
14622-47-0 |
C22H28O5 |
More |
| 2-[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]-1-[2-[[5-(methylaminomethy |
140695-21-2 |
C19H28N4O5S2 |
More |
| 4-({4-[2-(4-Chlorophenyl)-2-hydroxyethyl]-1-piperazinyl}methyl)-2,6-bi |
199467-52-2 |
C27H41Cl3N2O2 |
More |
| 2,4,9-Trimethylbenzo[b][1,8]naphthyridin-5-amine |
510721-85-4 |
C15H15N3 |
More |
| R(+)bay k 8644 |
98791-67-4 |
C16H15F3N2O4 |
More |
| (8S,11r,13s,14s,17s)-11-[4-[(e)-hydroxyiminomethyl]phenyl]-17-methoxy- |
199396-76-4 |
C28H35NO4 |
More |
| (2R)-2-[(5z)-5-(4-bromobenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-y |
300817-68-9 |
C15H14BrNO3S2 |
More |
| 6-[(4-Chlorophenyl)methyl]-4,5,7,8-tetrahydro-[1,3]thiazolo[5,4-d]azep |
36085-44-6 |
C14H18Cl3N3S |
More |
| 3-Fluoro-4-{[hydroxy(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthal |
185629-22-5 |
C23H26FNO4 |
More |
| (3R)-3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1,3-dih |
187523-36-0 |
C16H10ClF4NO2 |
More |
| (3R)-3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1h-indo |
187523-35-9 |
C16H10ClF4NO2 |
More |
| 3-Fluoro-4-{[(2r)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro- |
262433-54-5 |
C23H26FNO4 |
More |
| N-{2-[(3-cyano-5,7-dimethyl-2-quinolinyl)amino]ethyl}-3-methoxybenzami |
606101-83-1 |
C22H22N4O2 |
More |
| (2S,3s)-2,3-dihydroxysuccinic acid-(2r)-n,n-dimethyl-2-phenyl-1-[(3,4, |
133267-27-3 |
C26H37NO10 |
More |
| Sodium 3-[(1e)-3-anilino-3-oxo-1-propen-1-yl]-4,6-dichloro-1h-indole-2 |
153436-38-5 |
C18H11Cl2N2NaO3 |
More |
| 11-(4-Methyl-1-piperazinyl)-5h-dibenzo[b,e][1,4]diazepin-8-ol |
63687-94-5 |
C18H20N4O |
More |
| 11-(4-Methyl-1-piperazinyl)-5h-dibenzo[b,e][1,4]diazepin-2-yl trifluor |
183140-97-8 |
C19H19F3N4O3S |
More |
| 11-(4-Methyl-1-piperazinyl)dibenzo[b,f][1,4]oxazepin-2-yl trifluoromet |
183140-98-9 |
C19H18F3N3O4S |
More |
|
